These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12743076)

  • 1. Ribavirin in the treatment of SARS: A new trick for an old drug?
    Koren G; King S; Knowles S; Phillips E
    CMAJ; 2003 May; 168(10):1289-92. PubMed ID: 12743076
    [No Abstract]   [Full Text] [Related]  

  • 2. Ribavirin in the treatment of severe acute respiratory syndrome (SARS).
    van Vonderen MG; Bos JC; Prins JM; Wertheim-van Dillen P; Speelman P
    Neth J Med; 2003 Jul; 61(7):238-41. PubMed ID: 14567520
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of corticosteroids in SARS.
    Oba Y
    N Engl J Med; 2003 May; 348(20):2034-5; author reply 2034-5. PubMed ID: 12748321
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiviral treatment of SARS: can we draw any conclusions?
    Zhaori G
    CMAJ; 2003 Nov; 169(11):1165-6. PubMed ID: 14638651
    [No Abstract]   [Full Text] [Related]  

  • 5. Ribavirin for SARS in children.
    Cheng WT; Li CK; Leung TF; Li AM; Hon KL; Ng PC; Fok TF
    Clin Pediatr (Phila); 2004 Mar; 43(2):193-6. PubMed ID: 15024445
    [No Abstract]   [Full Text] [Related]  

  • 6. Pregnancy outcome after exposure to injectable ribavirin during embryogenesis.
    Rezvani M; Koren G
    Reprod Toxicol; 2006 Jan; 21(1):113-5. PubMed ID: 16122903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe acute respiratory syndrome: Relapse? Hospital infection?
    Tsang OT; Chau TN; Choi KW; Tso EY; Lim W; Chiu MC; Tong WL; Lee PO; Lam BH; Ng TK; Lai JY; Yu WC; Lai ST
    Emerg Infect Dis; 2003 Sep; 9(9):1180-1. PubMed ID: 14531379
    [No Abstract]   [Full Text] [Related]  

  • 8. Population pharmacokinetic modeling of plasma and intracellular ribavirin concentrations in patients with chronic hepatitis C virus infection.
    Wu LS; Rower JE; Burton JR; Anderson PL; Hammond KP; Baouchi-Mokrane F; Everson GT; Urban TJ; D'Argenio DZ; Kiser JJ
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2179-88. PubMed ID: 25645847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The war against an unknown pathogen: rising to the SARS challenge.
    Can Commun Dis Rep; 2003 May; 29(9):77-82. PubMed ID: 12739275
    [No Abstract]   [Full Text] [Related]  

  • 10. Ribavarin should be tested in clinical trials in combination with other antiviral agents for severe acute respiratory syndrome.
    Chu CM; Chan KS
    Chest; 2005 Dec; 128(6):4050. PubMed ID: 16354884
    [No Abstract]   [Full Text] [Related]  

  • 11. [SARS: a new emergency in the world health].
    Calza L; Manfredi R; Verucchi G; Chiodo F
    Recenti Prog Med; 2003; 94(7-8):284-94. PubMed ID: 12868233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribavirin trials and hantavirus--what we should not conclude.
    Marcus KA; Johann-Liang R; Powers JH
    Clin Infect Dis; 2005 May; 40(10):1550-1. PubMed ID: 15844085
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003.
    Leong HN; Ang B; Earnest A; Teoh C; Xu W; Leo YS
    Trop Med Int Health; 2004 Aug; 9(8):923-7. PubMed ID: 15303999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada.
    Knowles SR; Phillips EJ; Dresser L; Matukas L
    Clin Infect Dis; 2003 Oct; 37(8):1139-42. PubMed ID: 14523782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials and novel pathogens: lessons learned from SARS.
    Muller MP; McGeer A; Straus SE; Hawryluck L; Gold WL
    Emerg Infect Dis; 2004 Mar; 10(3):389-94. PubMed ID: 15109402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Emergency treatment for Middle Eastern coronaviruses (MERS-CoV].
    Nau JY
    Rev Med Suisse; 2013 Jun; 9(392):1394-5. PubMed ID: 23882919
    [No Abstract]   [Full Text] [Related]  

  • 17. Pro/con clinical debate: steroids are a key component in the treatment of SARS. Con: No, steroids are not a key component of the treatment regimen for SARS.
    Kargel MJ; Lapinsky SE
    Crit Care; 2004 Apr; 8(2):105-7. PubMed ID: 15515216
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers.
    Chiou HE; Liu CL; Buttrey MJ; Kuo HP; Liu HW; Kuo HT; Lu YT
    Chest; 2005 Jul; 128(1):263-72. PubMed ID: 16002945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study.
    Li SS; Cheng CW; Fu CL; Chan YH; Lee MP; Chan JW; Yiu SF
    Circulation; 2003 Oct; 108(15):1798-803. PubMed ID: 14504188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome.
    Wang WK; Chen SY; Liu IJ; Kao CL; Chen HL; Chiang BL; Wang JT; Sheng WH; Hsueh PR; Yang CF; Yang PC; Chang SC;
    Clin Infect Dis; 2004 Oct; 39(7):1071-5. PubMed ID: 15472864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.